Manulife (Manufacturers Life Insurance)’s NGM Biopharmaceuticals, Inc. Common Stock NGM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-17,508
| Closed | -$71.4K | – | 3088 |
|
|
2023
Q1 | $71.4K | Hold |
17,508
| – | – | ﹤0.01% | 2812 |
|
|
2022
Q4 | $87.9K | Buy |
17,508
+887
| +5% | +$4.45K | ﹤0.01% | 2825 |
|
|
2022
Q3 | $217K | Sell |
16,621
-342
| -2% | -$4.47K | ﹤0.01% | 2533 |
|
|
2022
Q2 | $217K | Buy |
16,963
+2,267
| +15% | +$29.1K | ﹤0.01% | 2613 |
|
|
2022
Q1 | $224K | Sell |
14,696
-3,168
| -18% | -$48.3K | ﹤0.01% | 2696 |
|
|
2021
Q4 | $316 | Buy |
17,864
+188
| +1% | +$3 | ﹤0.01% | 2576 |
|
|
2021
Q3 | $372K | Sell |
17,676
-1,292
| -7% | -$27.2K | ﹤0.01% | 2506 |
|
|
2021
Q2 | $374K | Buy |
18,968
+3,327
| +21% | +$65.6K | ﹤0.01% | 2636 |
|
|
2021
Q1 | $455K | Buy |
15,641
+123
| +0.8% | +$3.58K | ﹤0.01% | 2343 |
|
|
2020
Q4 | $470K | Buy |
15,518
+447
| +3% | +$13.5K | ﹤0.01% | 2234 |
|
|
2020
Q3 | $240K | Hold |
15,071
| – | – | ﹤0.01% | 2452 |
|
|
2020
Q2 | $295K | Sell |
15,071
-1,597
| -10% | -$31.3K | ﹤0.01% | 2267 |
|
|
2020
Q1 | $206K | Buy |
+16,668
| New | +$206K | ﹤0.01% | 2308 |
|